Visual Evoked Potential Abnormalities in Phelan-McDermid Syndrome.


Journal

Journal of the American Academy of Child and Adolescent Psychiatry
ISSN: 1527-5418
Titre abrégé: J Am Acad Child Adolesc Psychiatry
Pays: United States
ID NLM: 8704565

Informations de publication

Date de publication:
04 2022
Historique:
received: 19 04 2021
revised: 28 06 2021
accepted: 15 07 2021
pubmed: 26 7 2021
medline: 12 4 2022
entrez: 25 7 2021
Statut: ppublish

Résumé

The current study used visual evoked potentials (VEPs) to examine excitatory and inhibitory postsynaptic activity in children with Phelan-McDermid syndrome (PMS) and the association with genetic factors. PMS is caused by haploinsufficiency of SHANK3 on chromosome 22 and represents a common single-gene cause of autism spectrum disorder (ASD) and intellectual disability. Transient VEPs were obtained from 175 children, including 31 with PMS, 79 with idiopathic ASD, 45 typically developing controls, and 20 unaffected siblings of children with PMS. Stimuli included standard and short-duration contrast-reversing checkerboard conditions, and the reliability between these 2 conditions was assessed. Test-retest reliability and correlations with deletion size were explored in the group with PMS. Children with PMS and, to a lesser extent, those with idiopathic ASD displayed significantly smaller amplitudes and decreased beta and gamma band activity relative to TD controls and PMS siblings. Across groups, high intraclass correlation coefficients were obtained between standard and short-duration conditions. In children with PMS, test-retest reliability was strong. Deletion size was significantly correlated with P Children with PMS displayed distinct transient VEP waveform abnormalities in both time and frequency domains that might reflect underlying glutamatergic deficits that were associated with deletion size. A similar response pattern was observed in a subset of children with idiopathic ASD. VEPs offer a noninvasive measure of excitatory and inhibitory neurotransmission that holds promise for stratification and surrogate endpoints in ongoing clinical trials in PMS and ASD.

Identifiants

pubmed: 34303785
pii: S0890-8567(21)00474-3
doi: 10.1016/j.jaac.2021.07.006
pmc: PMC8782912
mid: NIHMS1727284
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

565-574.e1

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS105845
Pays : United States
Organisme : NIMH NIH HHS
ID : R21 MH107839
Pays : United States
Organisme : NIMH NIH HHS
ID : R34 MH100276
Pays : United States
Organisme : NINDS NIH HHS
ID : U54 NS092090
Pays : United States

Informations de copyright

Copyright © 2021 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.

Références

PLoS Genet. 2014 Sep 04;10(9):e1004580
pubmed: 25188300
Int J Dev Neurosci. 2014 Aug;36:90-7
pubmed: 24875778
Eur J Neurosci. 2018 Jul;48(2):1765-1788
pubmed: 29923646
J Autism Dev Disord. 2015 Apr;45(4):966-74
pubmed: 25239176
Mol Autism. 2013 Apr 27;4(1):9
pubmed: 23621888
Int Rev Neurobiol. 1959;1:47-163
pubmed: 14435355
Curr Opin Psychiatry. 2005 Mar;18(2):151-7
pubmed: 16639168
J Autism Dev Disord. 2001 Apr;31(2):247-8
pubmed: 11450824
J Am Acad Child Adolesc Psychiatry. 2017 Jun;56(6):466-474
pubmed: 28545751
Optom Vis Sci. 2009 Jun;86(6):708-16
pubmed: 19417712
Proc Natl Acad Sci U S A. 1980 Dec;77(12):7476-8
pubmed: 6938987
Neuroimage Clin. 2017 Jun 23;16:624-633
pubmed: 28971012
J Psychiatr Res. 2017 Aug;91:139-144
pubmed: 28346892
Mol Autism. 2013 Jun 11;4(1):18
pubmed: 23758760
Genes Brain Behav. 2003 Oct;2(5):255-67
pubmed: 14606691
J Autism Dev Disord. 2016 Jul;46(7):2508-13
pubmed: 26914612
Mol Autism. 2018 Apr 27;9:31
pubmed: 29719671
Biol Psychiatry. 2017 May 15;81(10):838-847
pubmed: 27450033
Front Hum Neurosci. 2017 May 26;11:259
pubmed: 28603492
Mol Autism. 2013 Jun 11;4(1):17
pubmed: 23758743
PLoS One. 2016 Oct 7;11(10):e0164422
pubmed: 27716799
Electroencephalogr Clin Neurophysiol Suppl. 1999;52:3-6
pubmed: 10590970
Ann Neurol. 2015 Nov;78(5):775-86
pubmed: 26332183
Front Neural Circuits. 2014 Jul 04;8:79
pubmed: 25071460
Child Neuropsychol. 2016;22(5):556-69
pubmed: 25833070
Biol Psychiatry. 2017 May 15;81(10):848-861
pubmed: 28434615
Mol Autism. 2010 Dec 17;1(1):15
pubmed: 21167025
Nature. 2013 Nov 14;503(7475):267-71
pubmed: 24132240
Epilepsia. 2005 Sep;46(9):1426-41
pubmed: 16146439
Doc Ophthalmol. 2016 Aug;133(1):1-9
pubmed: 27443562
J Autism Dev Disord. 1994 Oct;24(5):659-85
pubmed: 7814313
Int J Neurosci. 1995;80(1-4):181-201
pubmed: 7775048
J Neurosci. 2012 May 9;32(19):6525-41
pubmed: 22573675
Neuroimage. 2013 Feb 15;67:153-62
pubmed: 23194815
Mol Autism. 2016 Jun 27;7:30
pubmed: 27354901

Auteurs

Paige M Siper (PM)

Icahn School of Medicine at Mount Sinai, New York. Electronic address: Paige.siper@mssm.edu.

Mikaela A Rowe (MA)

Icahn School of Medicine at Mount Sinai, New York.

Sylvia B Guillory (SB)

Icahn School of Medicine at Mount Sinai, New York.

Audrey A Rouhandeh (AA)

Icahn School of Medicine at Mount Sinai, New York; Ferkauf Graduate School of Psychology, Yeshiva University, New York.

Julia L George-Jones (JL)

University of Texas at Austin.

Teresa Tavassoli (T)

School of Psychology and Clinical Language Sciences, University of Reading, United Kingdom.

Stacey Lurie (S)

Icahn School of Medicine at Mount Sinai, New York; Ferkauf Graduate School of Psychology, Yeshiva University, New York.

Jessica Zweifach (J)

Icahn School of Medicine at Mount Sinai, New York.

Jordana Weissman (J)

Icahn School of Medicine at Mount Sinai, New York.

Jennifer Foss-Feig (J)

Icahn School of Medicine at Mount Sinai, New York.

Danielle Halpern (D)

Icahn School of Medicine at Mount Sinai, New York.

M Pilar Trelles (MP)

Icahn School of Medicine at Mount Sinai, New York.

Maureen S Mulhern (MS)

Icahn School of Medicine at Mount Sinai, New York.

Chloe Brittenham (C)

Hunter College, New York.

James Gordon (J)

Hunter College, New York.

Vance Zemon (V)

Ferkauf Graduate School of Psychology, Yeshiva University, New York.

Joseph D Buxbaum (JD)

Icahn School of Medicine at Mount Sinai, New York.

Alexander Kolevzon (A)

Icahn School of Medicine at Mount Sinai, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH